Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Waisman Biomafacturing (WB) is at the forefront of the fight against COVID-19 with one vaccine and two therapeutic products in development. “Waisman Biomanufacturing’s mission is to advance novel vaccines and therapeutics into early human clinical trials,” says Carl Ross, MS, WB’s managing director. With its state-of-the-art cleanroom facility, WB provides manufacturing and testing services to …
The COVID-19 pandemic pivoted many daily life activities, such as work and school, to a home base. Healthcare was no exception. In March, the Waisman Center Clinics transitioned all of its services to telehealth appointments using phone and video platforms. The 10 interdisciplinary specialty clinics and the center’s autism treatment program, operated in partnership with …
Early infancy is characterized by rapid brain development that occurs alongside, and in response to, the development of cognitive and behavioral functions, including attention. Infants' ability to orient and sustain attention to stimuli develops in concert with refinement of the orienting network in frontoparietal regions of the brain.
Teachers vary in their ability to enact effective teaching practices. We randomly assigned 88 early education preservice teachers to standard teacher education or teacher education plus a 9-week mindfulness-based intervention. Using the Classroom Assessment Scoring System (CLASS) as our primary outcome, we assessed effective teaching practices at baseline and at a 6-month follow-up that occurred during full-time student teaching.
Birth weight (BW) at delivery is an important developmental milestone indicative of prenatal conditions and portends of the postnatal growth trajectory that will occur during infancy and childhood. Previous research has documented that there are also many physiological and health consequences of being born either small-for-gestational age (SGA) or large-for-gestational age (LGA).
Adults with Down syndrome (DS) are predisposed to Alzheimer’s disease (AD) and a characterization of glucose metabolism change throughout AD progression has yet to be performed in this population. Using FDG PET, regional glucose metabolism was evaluated across groups of cognitively stable DS (CS-DS), DS with mild cognitive impairment or Alzheimer’s disease (MCI-DS/AD), and healthy non-DS sibling controls.
